共 50 条
- [2] THE BIOAVAILABILITY OF THEOPHYLLINE SUSTAINED-RELEASE TABLETS CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1981, 30 (03): : 335 - 350
- [4] A MULTIPLE-DOSE, CROSSOVER COMPARISON OF 2 SUSTAINED-RELEASE THEOPHYLLINE TABLETS IN ASTHMATIC-CHILDREN DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (06): : 474 - 474
- [5] BIOAVAILABILITY AND MULTIPLE DOSE CHARACTERISTICS OF A NEW SUSTAINED-RELEASE THEOPHYLLINE TABLET ANNALS OF ALLERGY, 1980, 45 (06): : 355 - 359
- [6] COMPARATIVE BIOAVAILABILITY OF THEOPHYLLINE WHOLE AND HALVED SUSTAINED-RELEASE TABLETS SOUTH AFRICAN MEDICAL JOURNAL, 1987, 72 (03): : 175 - 178
- [8] Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (07): : 802 - 809
- [10] THE COMPARATIVE BIOAVAILABILITY OF A NEW SUSTAINED-RELEASE THEOPHYLLINE PREPARATION, QUIBRON T-SR, VS THEO-DUR AND SLO-PHYLLIN GYROCAPS CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1981, 30 (06): : 867 - 871